Long noncoding RNAs in B-cell development and activation

Area of Science:

• Immunology
• Molecular Biology
• Genomics

Background:

• Long noncoding RNAs (lncRNAs) are increasingly recognized for their regulatory roles in cellular processes.
• Their specific functions in B lymphocyte development and differentiation remain largely unexplored.

Purpose of the Study:

• To comprehensively identify and characterize lncRNAs expressed during B-cell development and activation.
• To investigate the regulatory roles of lncRNAs and their association with key B-cell transcription factors.

Main Methods:

• RNA sequencing (RNA-seq) and de novo transcript assembly were employed to identify lncRNAs across 11 stages of B-cell development.
• Chromatin immunoprecipitation sequencing (ChIP-seq) was used to classify lncRNAs and assess transcription factor binding.
• Comparative analysis with human lncRNAs identified orthologous transcripts.

Main Results:

• A catalog of 4516 lncRNAs expressed during B-cell development and activation was generated, with most being novel discoveries.
• 185 mouse lncRNAs with human orthologs were identified.
• 126 enhancer RNAs (eRNAs) were identified, correlating with nearby coding genes and indicating active enhancers.
• The transcription factor PAX5 was found to bind and regulate 109 lncRNAs in normal B cells and 184 lncRNAs in acute lymphoblastic leukemia.

Conclusions:

• This study provides a comprehensive resource of lncRNAs involved in B-cell development and activation.
• PAX5 plays a significant role in regulating lncRNA expression within the B-cell lineage.
• The identified lncRNAs and their regulatory interactions offer potential targets for understanding B-cell differentiation and associated malignancies.